Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Circulation|August 24, 2022
Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter DefibrillatorHanna-Kaisa Nordenswan, Pauli Pöyhönen, Jukka Lehtonen, et al.JACC. Advances|August 6, 2024
30-Year Trends in the Incidence, Characteristics, and Outcome of Cardiac Sarcoidosis in a Nationwide CohortPauli Pöyhönen, Jukka Lehtonen, Diana Velikanova, et al.Circulation. Arrhythmia and Electrophysiology|October 26, 2018
Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular BlockHanna-Kaisa Nordenswan, Jukka Lehtonen, Kaj Ekström, et al.Circulation. Arrhythmia and Electrophysiology|December 20, 2024
Magnetic Resonance Imaging in the Assessment of the Risk of Sudden Death in Cardiac Sarcoidosis: What Is Extensive or Significant Late Gadolinium Enhancement?Pauli Pöyhönen, Jukka Lehtonen, Suvi Syväranta, et al.Journal of the American Heart Association|March 4, 2021
Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide CohortsHanna-Kaisa Nordenswan, Jukka Lehtonen, Kaj Ekström, et al.European Heart Journal|June 24, 2019
Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registriesKaj Ekström, Jukka Lehtonen, Hanna-Kaisa Nordenswan, et al.Nature Communications|March 21, 2019
Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humansEevi Kaasinen, Outi Kuismin, Kristiina Rajamäki, et al.International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.Pageof 3